A project work on role of clinical pharmacist in a haemovigilance unit of a tertiary care hospital


A project work on role of clinical pharmacist in a haemovigilance unit of a tertiary care hospital


Rachel Pinto, Arun karki, Binai K Sankar and Deepti S.P
Reddy college of pharmacy


 International Journal of Hospital Pharmacy

Blood is a very important component of the human body. Blood constituents of about 7% of the total bodies’ weight. An average Adult body that is having a weight of 150-180 pounds will have approximately 4.7-5.5 liters of blood.
Blood is a fluid connective tissue that circulate continuously around the body, allowing the constant communication between tissues that are far away from each other. It transports:
•Oxygen from the lung to the tissues, and carbon dioxide from the tissues to the lungs or excretion.
•Nutrients from the alimentary tract to the tissues, and cell wash-es to the excretory organ, principally the kidney.
•Hormones secreted by endocrine glands to their target organs and tissues.
•Protective substance like Antibodies like to the site of infection •Clotting factor that coagulates blood, minimizing bleeding from ruptured blood vessel.
Blood Is composed of a clear, straw-colored, watery fluid called plasma in which there are several types of blood cell are sus-pended.
Blood plays a very important role in transport of nutrition and re-spiratory gases, act as a vehicle to transport hormones and en-zymes from their place or origin to the place where it is required, drain waste products, maintaining hemostasis, regulation of body temperature and, most importantly, act as a defense mechanism for the body.


Free Full-text PDF


How to cite this article:
Rachel Pinto, Arun karki, Binai K Sankar and Deepti S.P, A project work on role of clinical pharmacist in a haemovigilance unit of a tertia-ry care hospital. International Jour-nal of Hospital Pharmacy, 2018,3:10.


References:

1] Ross and Wilson Anatomy and physiology in health and illness,edi:Anne Waugh,Allison Grant. 11th edition ch:4(55-56):Pub:Elsiever.
2] who.in [internet]. World Health Organisation,Inc.;c[cited 2017 Jan] 1]. Available from: http://www.who.int/bloodsafety/Manual_on_Management,Maintenance_and_Use_of_Blood_Cold_Chain_Equipment.pdf
3] nih.gov [internet]. National heart lung blood institiute.Inc.;c[cited December 2016 10]. Available from: https://www.nhlbi.nih.gov/health/health-topics/topics/bt/whoneeds
4] nib.gov [internet]. National institute of biologicals. Inc.;c[cited December 2016 1] Available from: http://nib.gov.in/haemovigilance.html
5] ncbi.nlm.nih.gov [internet] Indian journal of anesthesia.;c[cited December 2016 28] Available from:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260299/
6] Osselear JC et al. An active hemovigilance programme characterizing by safety profile of 7347 platelet transfusion prepared with amotosalen Photochemical treatment Pub.Med.gov[internet] 2008 May[Cited 2016 December11];94(4):( 315-323) Available from: https://www.ncbi.nlm.gov/pubmed/18248574
7] Somagari D. R. et al. Haemovigilance study at a tertiary care hospital in the north-east of India
ISBT science series [internet] 2015 july[cited 2016 December 20];10(2): (61-64) Available from: http://onlinelibrary.wiley.com/doi/10.1111/voxs.12182/full
8] Negi G,Gaur SD,Kaur R.Blood transfusion safety: A study of adverse reactions at the blood bank of a tertiary care center.US PMC.advance biomedical research[internet] 29 october 2015 [Cited 2016 Dec 20]4(437):(130-150) Available from:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673702/
9] Bhattacharya P,Marwaha M, Dhawan K et al.Transfusion-related adverse events at the tertiary care center in North India: An institutional hemovigilance effort Asian J Transfus Sci[internet]2011 July[Cited 2017 Jan];5(2):(164-170) Available from; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159249/
10] Azizi S, Tabary S.Z, Soleimani A.Prevalence of Acute Blood Transfusion Reactions in Mazandaran Heart Center, Sari, Iran Med Arch[internet]2014 April[Cited 2017 January 10];68(2):(137-139) Available format: https://www.ncbi.nlm.nih.gov/pubmed/24937941
11] Devi AM, Gakihonlungpou KG. Leukodepletion status of blood products and transfusion reactions in thalassemic patients. KAU[internet] 2014 May [Cited 2017 January 13];5(1):(29-31) Available from: http://www.jahjournal.org/article.asp?issn=1658-5127;year=2014;volume=5;issue=1;spage=29;epage=31;aulast=Shanthala
13] Paula M, Cohen hannah. Serious Hazards of Transfusion(SHOT)hemovigilance and progress is improving tranfusion safety.PMC[internet]2013 September [Cited 2017 January 20];163(3): (304-314) Available at: